Comment on

• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. Grimwade D, et al. Blood. 1998 Oct 1;92(7):2322-33. Blood. 1998. PMID: 9746770 Clinical Trial.
• Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.

  Zhu YM, Das-Gupta EP, Russell NH. Zhu YM, et al. Blood. 1999 Jul 15;94(2):733-40. Blood. 1999. PMID: 10397740
• Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications.

  Wong IH, Ng MH, Huang DP, Lee JC. Wong IH, et al. Blood. 2000 Mar 15;95(6):1942-9. Blood. 2000. PMID: 10706859